Picard Medical (PMI) Shares Outstanding (Weighted Average) (2024 - 2026)

Picard Medical has reported Shares Outstanding (Weighted Average) for 3 years, with the latest figure at $74.4 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 834.77% year-over-year to $74.4 million; the trailing twelve-month figure through Mar 2026 stood at $74.4 million (up 834.77% YoY), and the FY2025 full-year result was $36.2 million, up 356.13% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $74.4 million, up from $36.2 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $74.4 million in Q1 2026, with the low at $7.9 million in Q2 2024.
• Historically, Shares Outstanding (Weighted Average) has averaged $22.1 million across 3 years, with a median of $9.1 million in 2025.
• Annual changes were most pronounced in 2025 — Shares Outstanding (Weighted Average) soared 30.1% — and 2026, when it jumped 834.77%.
• Picard Medical's Shares Outstanding (Weighted Average) stood at $7.9 million in 2024, then surged by 356.13% to $36.2 million in 2025, then soared by 105.44% to $74.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $74.4 million (Q1 2026), $36.2 million (Q4 2025), and $23.7 million (Q3 2025), per Business Quant data.